AgingResearch.NewsJoin free

post-COVID-19 period

Exposure

1 paper1 finding

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

  • 1 lab in 1 country
  • Funder: Ministero della Salute
  • Humans1

Associations

1

Ideal CVH

upin humans1OR 1.32

1 study

  1. post-COVID-19 period is associated with ideal CVH in humans (OR 1.32; 95% CI 1.24-1.40).

    “The post-COVID-19 period was independently associated with higher odds of ideal CVH (OR 1.32; 95% CI 1.24-1.40).”

    Humansadjusted for age, sex, and year of assessment

    Temporal Trends in Cardiovascular Health Metrics in Italy, 2015-2024: A Ten-Year Report from the Longevity Check-Up (Lookup) 8+ Study

    Medical sciences (Basel, Switzerland)30 Oct 2025

Latest

Related